CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...